AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29219093 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 595
Study 26453108 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acetaminophen
Number of subjects: 0
Study 26453108 — intervention group
Group type: COMPARATOR
Intervention: Strong opioids (up to 100mg/day)
Number of subjects: 0
Study 26453108 — intervention group
Group type: COMPARATOR
Intervention: Strong opioids
Number of subjects: 0
Study 26453108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26453108 — intervention group
Group type: EXPERIMENTAL
Intervention: Step III analgesics
Number of subjects: 0
Study 23860019 — intervention group
Group type: EXPERIMENTAL
Intervention: Real PKP treatment (1 treatment weekly for 5 weeks)
Number of subjects: 70
Study 23860019 — intervention group
Group type: COMPARATOR
Intervention: Sham PKP treatment (1 treatment weekly for 5 weeks)
Number of subjects: 70
Study 23860019 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 70
Study 22102862 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked anti-CD20 (rituximab)
Number of subjects: 156
Study 22102862 — intervention group
Group type: COMPARATOR
Intervention: Masked placebo
Number of subjects: 156
Study 19170232 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CAF (300 mg/m(2), 30 mg/m(2), 300 x 2 mg/m(2) over 4 cycles)
Number of subjects: 245
Study 19170232 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose CAF (400 mg/m(2), 40 mg/m(2), 400 x 2 mg/m(2) over 6 cycles)
Number of subjects: 245
Study 19170232 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose CAF (600 mg/m(2), 60 mg/m(2), 600 x 2 mg/m(2) over 4 cycles)
Number of subjects: 245
Study 16515705 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating ibuprofen (10 mg/kg) and acetaminophen (15 mg/kg)
Number of subjects: 70
Study 16515705 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating ibuprofen and acetaminophen
Number of subjects: 70
Study 15266074 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocyte chromosomal translocations assay
Number of subjects: 0
Study 15266074 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronuclei assay
Number of subjects: 0
Study 15266074 — intervention group
Group type: EXPERIMENTAL
Intervention: HPRT mutations assay
Number of subjects: 0
Study 15266074 — intervention group
Group type: EXPERIMENTAL
Intervention: Apoptotic cells assay
Number of subjects: 0
Study 11258130 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac-sodium by short time i.v.-infusion (30 min)
Number of subjects: 59
Study 9190982 — intervention group
Group type: COMPARATOR
Intervention: ip Carboplatin 400 mg/m2 Day 1 q 28 days (CBDCA)
Number of subjects: 111
Study 9190982 — intervention group
Group type: EXPERIMENTAL
Intervention: ip interferon‐alpha 25 x 10(6) U Day 1 + ip carboplatin 400 mg/m2 Day 2 q 28 days (CBDCA + IFN)
Number of subjects: 111
Study 8466006 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide wire technique
Number of subjects: 138
Study 8466006 — intervention group
Group type: COMPARATOR
Intervention: Direct method
Number of subjects: 138
Study 8466006 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide wire technique in female patients
Number of subjects: 138
Study 8466006 — intervention group
Group type: COMPARATOR
Intervention: Direct technique in female patients
Number of subjects: 138
Study 8466006 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide wire technique in male patients
Number of subjects: 138
Study 8466006 — intervention group
Group type: COMPARATOR
Intervention: Direct technique in male patients
Number of subjects: 138
Study 8466006 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide wire technique in patients with thready pulse
Number of subjects: 138
Study 3514687 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol
Number of subjects: 31
Study 3514687 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 31
Study 31016886 — intervention group
Group type: EXPERIMENTAL
Intervention: Asparagus consumption (specific number of spears not detailed)
Number of subjects: 42
Study 31016886 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinetic-pharmacodynamic model
Number of subjects: 42
Study 29485527 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe depressive symptoms (BDI‐II cutoff)
Number of subjects: 1075
Study 29485527 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status and quality of life
Number of subjects: 1075
Study 29485527 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1075
Study 29485527 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of individuals with below target age predicted fitness
Number of subjects: 1075
Study 29485527 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant use among women with moderate to severe depressive symptoms
Number of subjects: 1075
Study 26810378 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay for performance (P4P) incentives for community physicians
Number of subjects: 323812
Study 26810378 — intervention group
Group type: COMPARATOR
Intervention: Nonincentivized community physicians
Number of subjects: 323812
Study 25078754 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning-centered strategy (LCS)
Number of subjects: 20
Study 25078754 — intervention group
Group type: COMPARATOR
Intervention: Teaching-centered strategy (TCS)
Number of subjects: 20
Study 22540436 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety sensitivity
Number of subjects: 197
Study 22540436 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion dysregulation
Number of subjects: 197
Study 19798576 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 38
Study 19798576 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 38
Study 17599425 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure <120 mm Hg (more intensive goal)
Number of subjects: 4733
Study 17599425 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure <140 mm Hg (less intensive goal)
Number of subjects: 4733
Study 15848601 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (25 to 50 mg/day)
Number of subjects: 12
Study 15848601 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (4 to 8 mg/day)
Number of subjects: 12
Study 15848601 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 to 40 mg/day)
Number of subjects: 12
Study 15848601 — intervention group
Group type: COMPARATOR
Intervention: Control (no hypertension)
Number of subjects: 12
Study 12709129 — intervention group
Group type: EXPERIMENTAL
Intervention: High resolution ultrasound (HRUS) scanning
Number of subjects: 20
Study 12709129 — intervention group
Group type: COMPARATOR
Intervention: Photography
Number of subjects: 20
Study 10527967 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutational screening of testosterone 5‐alpha reductase type 1
Number of subjects: 23
Study 10527967 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutational screening of prostaglandin F2alpha receptor
Number of subjects: 23
Study 10527967 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutational screening of endothelin 1
Number of subjects: 23
Study 8577020 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinks with increasing carbohydrate content (45 to 90 g/L) at constant osmolarity (330 mOsm/kg)
Number of subjects: 12
Study 8577020 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinks with constant carbohydrate content (60 g/L) but varying osmolarity (243 to 374 mOsm/kg)
Number of subjects: 12
Study 1960303 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 145
Study 1960303 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 145
Study 6801877 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin administration
Number of subjects: 10
Study 2420602 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 0
Study 2420602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin, vinblastine
Number of subjects: 0
Study 2420602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin, etoposide, cisplatin
Number of subjects: 0
Study 2420602 — intervention group
Group type: COMPARATOR
Intervention: Etoposide and cisplatin
Number of subjects: 0
Study 31471911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 31471911 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0
Study 31471911 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CBT and sertraline
Number of subjects: 0
Study 31471911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30104492 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase integral accumulation algorithm
Number of subjects: 1
Study 30104492 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Hough transform (RHT) algorithm
Number of subjects: 1
Study 30104492 — intervention group
Group type: EXPERIMENTAL
Intervention: Unambiguous phase differences
Number of subjects: 1
Study 27332968 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week Internet-based, tailored exercise program
Number of subjects: 81
Study 27332968 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 24915929 — intervention group
Group type: COMPARATOR
Intervention: Latent Semantic Analysis (LSA) applied to picture book narratives
Number of subjects: 0
Study 24915929 — intervention group
Group type: COMPARATOR
Intervention: Latent Semantic Analysis (LSA) applied to a more demanding narrative recall task
Number of subjects: 0
Study 22832887 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment with a sling
Number of subjects: 60
Study 22832887 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with a stainless steel 3.5‐mm reconstruction plate
Number of subjects: 60
Study 20150572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg
Number of subjects: 1043
Study 20150572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 15 mg/kg
Number of subjects: 1043
Study 20150572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1043
Study 20150572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (both doses)
Number of subjects: 1043
Study 18208932 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g glucose
Number of subjects: 0
Study 18208932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15728051 — intervention group
Group type: EXPERIMENTAL
Intervention: Large volume infusion (2 mL/kg per hour fasting) of compound sodium lactate solution
Number of subjects: 80
Study 15728051 — intervention group
Group type: COMPARATOR
Intervention: Small volume infusion (3 mL/kg) of compound sodium lactate solution
Number of subjects: 80
Study 11533541 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring (group 1)
Number of subjects: 90
Study 11533541 — intervention group
Group type: COMPARATOR
Intervention: No BIS monitoring (group 2)
Number of subjects: 90
Study 9766454 — intervention group
Group type: EXPERIMENTAL
Intervention: Braden Scale assessment every 48 to 72 hours for 1 to 4 weeks
Number of subjects: 843
Study 9766454 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk assessment on admission
Number of subjects: 843
Study 9766454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing assessment in SNFs and VAMCs
Number of subjects: 843
Study 9766454 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment at 48 to 72 hours after admission in tertiary care
Number of subjects: 843
Study 8311374 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepaid care in capitated health plans
Number of subjects: 800
Study 8311374 — intervention group
Group type: COMPARATOR
Intervention: Fee-for-service care
Number of subjects: 800
Study 3041358 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandoglobulin (500 mg/kg)
Number of subjects: 0
Study 3041358 — intervention group
Group type: COMPARATOR
Intervention: Albumin (control)
Number of subjects: 0
Study 3041358 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandoglobulin (in vitro addition)
Number of subjects: 0
Study 29890286 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 375
Study 29890286 — intervention group
Group type: COMPARATOR
Intervention: Control (Routine Care)
Number of subjects: 375
Study 26474870 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily
Number of subjects: 1613
Study 26474870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1613
Study 25312005 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Development Teams (CDT)
Number of subjects: 51
Study 25312005 — intervention group
Group type: COMPARATOR
Intervention: Independent county implementation strategy (IND)
Number of subjects: 51
Study 22057836 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (3 x 20 minutes a week for 12 weeks)
Number of subjects: 67
Study 22057836 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 20565161 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 min/week of moderate intensity exercise
Number of subjects: 60
Study 20565161 — intervention group
Group type: COMPARATOR
Intervention: Contact control
Number of subjects: 60
Study 17956570 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM)
Number of subjects: 22
Study 17956570 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine collagen membrane (BME)
Number of subjects: 22
Study 17956570 — intervention group
Group type: COMPARATOR
Intervention: No membrane (Control)
Number of subjects: 22
Study 17956570 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant exposure
Number of subjects: 22
Study 15997871 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 plus antiretrovirals (ARV)
Number of subjects: 28
Study 15997871 — intervention group
Group type: COMPARATOR
Intervention: Control (ARV only)
Number of subjects: 28
Study 12115019 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral activated charcoal (50 g)
Number of subjects: 1479
Study 12115019 — intervention group
Group type: COMPARATOR
Intervention: Supportive care only
Number of subjects: 1479
Study 9459375 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation for 8 weeks
Number of subjects: 37
Study 9459375 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 37
Study 9385113 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment under non-identifiable assumptions
Number of subjects: 0
Study 9385113 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted log-rank tests
Number of subjects: 0
Study 9385113 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment effect estimation
Number of subjects: 0
Study 2571864 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine insulin (50 mU/kg per hour)
Number of subjects: 8
Study 2571864 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (50 mU/kg per hour)
Number of subjects: 8
Study 2571864 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insulins (human and porcine)
Number of subjects: 8
Study 354938 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 68
Study 354938 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 68
Study 354938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 354938 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam vs Baclofen
Number of subjects: 68
Study 354938 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Clonazepam and Baclofen
Number of subjects: 68
Study 30564806 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading of dental implants with SLActive surface
Number of subjects: 56
Study 30564806 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading of dental implants with SLActive surface
Number of subjects: 56
Study 29673361 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ1 and SQ2 (Surprise Questions)
Number of subjects: 28
Study 29673361 — intervention group
Group type: COMPARATOR
Intervention: SQ1 (Surprise Question 1)
Number of subjects: 28
Study 29673361 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ2 (Surprise Question 2)
Number of subjects: 28
Study 29673361 — intervention group
Group type: COMPARATOR
Intervention: No additional information
Number of subjects: 28
Study 26849259 — intervention group
Group type: EXPERIMENTAL
Intervention: Large machinery-related injuries
Number of subjects: 7420
Study 26849259 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender, increasing age, state of residence, history of prior injury, increasing hours worked per week
Number of subjects: 7420
Study 24555575 — intervention group
Group type: EXPERIMENTAL
Intervention: Submandibular gland transfer
Number of subjects: 65
Study 24555575 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 65
Study 23286612 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic outreach and engagement within 24 hours of discharge
Number of subjects: 1994
Study 23286612 — intervention group
Group type: COMPARATOR
Intervention: Delayed telephonic outreach and engagement 48 hours after discharge notification
Number of subjects: 1994
Study 20851724 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol drink preload
Number of subjects: 40
Study 20851724 — intervention group
Group type: COMPARATOR
Intervention: Energy-matched control (alcohol-free juice)
Number of subjects: 40
Study 18201432 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional aerosol therapy (Group A)
Number of subjects: 30
Study 18201432 — intervention group
Group type: COMPARATOR
Intervention: Abbreviated aerosol therapy with new spacer mouth mask (Group B)
Number of subjects: 30
Study 15716985 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (5 mg/kg/day for first 3 days)
Number of subjects: 56
Study 15716985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 15716985 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 56
Study 12093850 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 embryo transfer (after culture in human tubal fluid)
Number of subjects: 235
Study 12093850 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 embryo transfer (after culture in sequential media)
Number of subjects: 235
Study 12093850 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 embryo transfer using Irvine blastocyst medium
Number of subjects: 235
Study 12093850 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 embryo transfer using G1.2/G2.2 medium
Number of subjects: 235
Study 12093850 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 embryo transfer using Cook blastocyst medium
Number of subjects: 235
Study 10069787 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL/kg body weight of 0.9% saline infusion
Number of subjects: 10
Study 10069787 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion in normal subjects
Number of subjects: 10
Study 7568536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (individual)
Number of subjects: 0
Study 7568536 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital therapy
Number of subjects: 0
Study 7568536 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal approach
Number of subjects: 0
Study 7568536 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 2208537 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl chloride
Number of subjects: 120
Study 2208537 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (0.2 ml one per cent intradermally)
Number of subjects: 120
Study 2208537 — intervention group
Group type: COMPARATOR
Intervention: No anaesthetic
Number of subjects: 120
Study 156069 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of chemotherapeutic agents (15 drugs)
Number of subjects: 41
Study 30936583 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO simulations for perfusion students
Number of subjects: 0
Study 30936583 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO simulations for non‐perfusion students
Number of subjects: 0
Study 28294174 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA+DHA (4 g/day)
Number of subjects: 16
Study 28294174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 25066503 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic plus VR training (KTVR)
Number of subjects: 32
Study 25066503 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic training (KT)
Number of subjects: 32
Study 24497661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT‐I)
Number of subjects: 45
Study 24497661 — intervention group
Group type: COMPARATOR
Intervention: Monitor-only waitlist control
Number of subjects: 45
Study 22935854 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching program (three exercises of hamstrings stretching of 20 seconds per exercise, three sessions a week for 12 weeks)
Number of subjects: 58
Study 22935854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hamstring stretching program)
Number of subjects: 58
Study 22935854 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching program
Number of subjects: 58
Study 22935854 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 19335986 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule metadoxine 500mg tid po
Number of subjects: 254
Study 19335986 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2 pillows tid po
Number of subjects: 254
Study 18089265 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 0
Study 15321816 — intervention group
Group type: EXPERIMENTAL
Intervention: AB-yogurt (10^7 colony-forming units of both Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12/mL) twice daily after a meal for 6 weeks
Number of subjects: 59
Study 15321816 — intervention group
Group type: COMPARATOR
Intervention: Milk placebo
Number of subjects: 59
Study 11597538 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT group
Number of subjects: 46
Study 11597538 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46